Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential thyroid hormone replacement pilot study in hypothyroidism
ACTRN12621000237886Phase 2Active, not recruiting
- Sponsor
- QIMR Berghofer Medical Research Institute
- Start
- May 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of levothyroxine sodium, liothyronine and thyroid, porcine in hypothyroidism, sponsored by QIMR Berghofer Medical Research Institute. Primary endpoints: Recruitment feasibility, Treatment adherence feasibility and 1 more. Started May 2021; status: active, not recruiting.
02
Drugs
levothyroxine sodiumliothyroninethyroid, porcine
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on ACTRN12621000237886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000237886.